# Immunis, Inc.

> Immunis, Inc. is a private, clinical-stage biotechnology company in Irvine, California developing
> immunomodulatory secretome biologics — the mixture of proteins and factors secreted by stem cells,
> rather than the cells themselves — for age- and disease-related immune decline.

Immunis publishes NO developer program and NO API. There is no developer portal, no documentation
site, no OpenAPI/AsyncAPI/GraphQL/gRPC/SOAP contract, no SDK or package on any public registry, no
MCP server, no A2A agent card, no webhooks and no /llms.txt of the company's own. This file is
generated by API Evangelist from the company's public web surface; it is not published by Immunis.

The only machine-readable endpoint on immunisbiomedical.com is the default WordPress REST API at
https://immunisbiomedical.com/wp-json/ (WordPress core plus Jetpack, Yoast, Akismet, Contact Form 7
and HubSpot plugin namespaces). That is the content-management interface of the marketing site, not
an Immunis product API, and it is not catalogued as one.

## Company

- [Immunis, Inc.](https://immunisbiomedical.com/): Corporate site and clinical-trial recruitment.
- [Mission](https://immunisbiomedical.com/mission/): Company mission.
- [Technology](https://immunisbiomedical.com/technology/): Secretome biologics platform.
- [Pipeline](https://immunisbiomedical.com/pipeline/): Development pipeline.
- [Leadership](https://immunisbiomedical.com/leadership/): Executive and scientific leadership.
- [Contact](https://immunisbiomedical.com/contact/): contact@immunisbiomedical.com
- [LinkedIn](https://www.linkedin.com/company/immunisbiomedical/): Company page.

## Programs

- [STEM-MYO Program](https://immunisbiomedical.com/stem-myo-program/): IMM01-STEM for muscle atrophy
  and sarcopenia; [Phase 1/2a Clinical Trial](https://immunisbiomedical.com/stem-myo-program/phase-1-2a-clinical-trial/).
- [STEM-META Program](https://immunisbiomedical.com/stem-meta-program/): [Phase 2 Clinical Trial](https://immunisbiomedical.com/stem-meta-program/phase-2-clinical-trial/).
- [STEM-K9 Program](https://immunisbiomedical.com/animal-health/): Veterinary / animal-health program.
- [About IMM01-STEM](https://immunisbiomedical.com/about-imm01-stem/)
- [About multi-active biologics](https://immunisbiomedical.com/about-secretome-biologics/)

## News

- [Press Releases](https://immunisbiomedical.com/press-releases/): Dated company announcements.
  Note: the site's RSS feed at https://immunisbiomedical.com/feed/ returns zero items because press
  releases are a custom post type that is not syndicated.

## API Evangelist artifacts in this repository

- [well-known/immunis-well-known.yml](../well-known/immunis-well-known.yml): Probe record — every
  /.well-known/ path returned 404 on both apex and www.
- [security/immunis-domain-security.yml](../security/immunis-domain-security.yml): Probed TLS/DNS
  posture (TLS 1.3, SPF present; no HSTS, no DNSSEC, no CAA, no DMARC).

## Optional

- Generated: 2026-08-23 by the API Evangelist enrichment pipeline (method: generated).
- Source: https://immunisbiomedical.com/ and its sitemap.